Silence Therapeutics plc
- SLN
- NASDAQ
- Biotechnology
- RNA Therapeutics (siRNA)
- Rare Disease Drugs
$19.58
Today +125.58%Quote Oct 19, 2026, 08:00 PM UTC
−31.65%over the last month
Max drawdown −31.7%From 1-month high −31.7%3 months −17.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Silence Therapeutics
Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas include hematological, cardiovascular, and various rare and metabolic conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
88
Market value
$2.78B
Quote Oct 19
Analyst target
$20.00
+2.1% from here
Floor
$12.24
37.5% below price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SLNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free